ArticlePlanta2025
Hyssopus officinalis: MicroRNA-mediated regulation of terpenoid biosynthesis and defense metabolites.
Article in Planta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MAIN
conclusionThis study provides an experimental identification of miRNAs in Hyssop and a prediction of mRNA targets with an eye toward miRNA-mediated regulation of terpenoid biosynthesis. This can help to design future metabolic engineering attempts to improve the yield and quality of source species and unravel its therapeutic potential. MicroRNAs (miRNAs) are important post-transcriptional regulators of plant and animal gene expression. They bind to ARGONAUTE (AGO) proteins to form RNA induced silencing complexes (RISCs) and use base pairing to guide RISC to complementary mRNA for repression. The Lamiaceae family is a rich resource of terpenoids with important commercial and pharmaceutical uses, but little is known about miRNA-mediated control of terpenoid biosynthesis in these species. Here, we applied Trans-kingdom, rapid, affordable purification of RISCs coupled to small RNA sequencing (TraPR-seq) to identify AGO-bound small RNAs in Hyssop (Hyssopus officinalis L.), an important medicinal herb. We identify 15 conserved and 42 novel miRNA families, of which 8 were predicted to be of potential relevance to terpenoid biosynthesis. We also uncover several plausible miRNA targets encoding innate immunity regulators and identify one miRNA as a possible master regulator of defense with targets not only in terpenoid biosynthesis, but also including typical defense regulators such as receptor-like kinases and WRKY transcription factors, and its role in defense responses was boosted by its identification as a confident trigger of phasiRNA production. Our study provides the basis for future exploitation of miRNA regulatory networks for production of valuable terpenoids in Hyssop and gives insight into how miRNAs may coordinately control the expression of defense regulators and defense metabolite production.
Indexed as
Identifiers
40670696What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.